RETRACTION: HnRNP A1-mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395 (vol 39, 116, 2020) (Retraction of Vol 39, Pg 116, 2020)
单位：[1]Huazhong Univ Sci & Technol,Tongji Hosp,Tongji Med Coll,Dept Urol,Wuhan 430030,Peoples R China华中科技大学同济医学院附属同济医院外科学系泌尿外科[2]Hubei Inst Urol, Wuhan 430030, Peoples R China[3]Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA[4]Xiamen Univ, Affiliated Hosp 1, Dept Urol, Xiamen 361000, Peoples R China[5]Peoples Hosp Shenzhen City, Dept Urol, Shenzhen 518000, Peoples R China
第一作者单位：[1]Huazhong Univ Sci & Technol,Tongji Hosp,Tongji Med Coll,Dept Urol,Wuhan 430030,Peoples R China[2]Hubei Inst Urol, Wuhan 430030, Peoples R China
通讯作者：
通讯机构：[1]Huazhong Univ Sci & Technol,Tongji Hosp,Tongji Med Coll,Dept Urol,Wuhan 430030,Peoples R China[2]Hubei Inst Urol, Wuhan 430030, Peoples R China
推荐引用方式(GB/T 7714)：
Sun Guoliang,Zhou Hui,Chen Ke,et al.RETRACTION: HnRNP A1-mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395 (vol 39, 116, 2020) (Retraction of Vol 39, Pg 116, 2020)[J].JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH.2023,42(1):doi:10.1186/s13046-023-02613-4.
APA：
Sun, Guoliang,Zhou, Hui,Chen, Ke,Zeng, Jin,Zhang, Yangjun...&Xu, Hua.(2023).RETRACTION: HnRNP A1-mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395 (vol 39, 116, 2020) (Retraction of Vol 39, Pg 116, 2020).JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH,42,(1)
MLA：
Sun, Guoliang,et al."RETRACTION: HnRNP A1-mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395 (vol 39, 116, 2020) (Retraction of Vol 39, Pg 116, 2020)".JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH 42..1(2023)
医学